Related Experiment Video
Updated: Aug 6, 2026

A Visual Assay to Monitor T6SS-mediated Bacterial Competition
Published on: March 20, 2013
Piecing together the puzzle: current knowledge and open questions about the Klebsiella pneumoniae type VI secretion
Leticia Miranda Santos Lery1, Paulo Ricardo Batista2
1Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Microbiologia Celular, Rio de Janeiro, RJ, Brasil.
Abstract:
Klebsiella pneumoniae (Kp) is currently a top priority for the development of alternative therapeutic strategies, according to the World Health Organisation, due to serious concerns regarding infections caused by multiple drug resistant (MDR) bacteria. The convergence of hypervirulence and MDR represents a major threat to public health worldwide. Kp displays an extensive genomic diversity, reflecting a variable repertoire of resistance and virulence factors. Despite this heterogeneity, the type VI secretion system (T6SS) is encoded in most Kp-genomes and plays important roles in competition and pathogenesis. The T6SS is a large macromolecular complex assembled in the cytoplasm that spans the inner and outer membranes. Upon activation, it undergoes conformational changes allowing the delivery of effectors into the extracellular milieu or target cells. Herein, we summarise the current knowledge on the Kp-T6SS, presenting a chronological overview of published studies, discussing the mechanisms, signals, and regulators involved in T6SS expression. Next, we detail both predicted and characterised effector proteins, including Tle1, Pld1 and VgrG4. Finally, we discuss the presence of Kp-T6SS in mobile genetic elements or in clinical samples, highlighting the importance of genomic vigilance and Kp-T6SS detection in high-risk cases. This review integrates available evidence, identifies knowledge gaps, and outlines future directions.
Insights
Klebsiella pneumoniae infections are a major threat due to multidrug resistance (MDR). The type VI secretion system (T6SS) in K. pneumoniae is crucial for its virulence and competitiveness, requiring further study for therapeutic development.
Area of Science:
- Microbiology
- Genomics
- Molecular Biology
Background:
- Klebsiella pneumoniae (Kp) poses a significant global health threat due to multidrug-resistant (MDR) infections.
- The co-occurrence of hypervirulence and MDR in Kp exacerbates this public health crisis.
- K. pneumoniae exhibits substantial genomic diversity, influencing its resistance and virulence capabilities.
Purpose of the Study:
- To provide a comprehensive review of the Klebsiella pneumoniae type VI secretion system (Kp-T6SS).
- To explore the mechanisms, regulation, and effector functions of the Kp-T6SS.
- To highlight the clinical relevance and genomic surveillance of Kp-T6SS.
Main Methods:
- Chronological review of published literature on Kp-T6SS.
- Analysis of genomic data for T6SS presence and variability.
- Characterization of Kp-T6SS effector proteins (e.g., Tle1, Pld1, VgrG4).
Main Results:
- The type VI secretion system (T6SS) is present in most Kp genomes and is vital for pathogenesis and interbacterial competition.
- Various effector proteins, including Tle1, Pld1, and VgrG4, are associated with Kp-T6SS function.
- Kp-T6SS is found on mobile genetic elements and in clinical isolates, underscoring its epidemiological importance.
Conclusions:
- Understanding Kp-T6SS mechanisms and effectors is critical for developing novel therapeutic strategies against MDR Kp.
- Genomic vigilance and routine detection of Kp-T6SS in high-risk clinical settings are essential.
- Further research is needed to fully elucidate Kp-T6SS regulation and its role in virulence.
Related Concept Videos
Gram-negative Bacterial Protein Secretion Systems
Bacterial Translocation and Protein Secretion
Regulation of Bacterial Virulence
Mechanism of Conjugation
Viral Replication: Lytic Cycle
Formation of Lipopolysaccharides
